377 related articles for article (PubMed ID: 33309205)
41. [Oncofertility and breast cancer].
Sonigo C; Grynberg M; Bringer S; Sermondade N
Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738
[TBL] [Abstract][Full Text] [Related]
42. New trends in female fertility preservation: in vitro maturation of oocytes.
Berwanger AL; Finet A; El Hachem H; le Parco S; Hesters L; Grynberg M
Future Oncol; 2012 Dec; 8(12):1567-73. PubMed ID: 23231518
[TBL] [Abstract][Full Text] [Related]
43. Fertility Preservation in Women with Turner Syndrome: A Comprehensive Review and Practical Guidelines.
Oktay K; Bedoschi G; Berkowitz K; Bronson R; Kashani B; McGovern P; Pal L; Quinn G; Rubin K
J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):409-416. PubMed ID: 26485320
[TBL] [Abstract][Full Text] [Related]
44. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
45. Current and Future Perspectives for Improving Ovarian Tissue Cryopreservation and Transplantation Outcomes for Cancer Patients.
Lee S; Ozkavukcu S; Ku SY
Reprod Sci; 2021 Jun; 28(6):1746-1758. PubMed ID: 33791995
[TBL] [Abstract][Full Text] [Related]
46. Impact of first-line cancer treatment on the follicle quality in cryopreserved ovarian samples from girls and young women.
Pampanini V; Wagner M; Asadi-Azarbaijani B; Oskam IC; Sheikhi M; Sjödin MOD; Lindberg J; Hovatta O; Sahlin L; Björvang RD; Otala M; Damdimopoulou P; Jahnukainen K
Hum Reprod; 2019 Sep; 34(9):1674-1685. PubMed ID: 31411325
[TBL] [Abstract][Full Text] [Related]
47. Human oocyte and ovarian tissue cryopreservation and its application.
Tao T; Del Valle A
J Assist Reprod Genet; 2008 Jul; 25(7):287-96. PubMed ID: 18670872
[TBL] [Abstract][Full Text] [Related]
48. Cryopreservation of ovarian tissue as a method for fertility preservation in women.
Hončová Veronika
Ceska Gynekol; 2023; 88(1):44-51. PubMed ID: 36858973
[TBL] [Abstract][Full Text] [Related]
49. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation.
Dittrich R; Lotz L; Keck G; Hoffmann I; Mueller A; Beckmann MW; van der Ven H; Montag M
Fertil Steril; 2012 Feb; 97(2):387-90. PubMed ID: 22177311
[TBL] [Abstract][Full Text] [Related]
50. Fertility preservation in women after the cancer.
Lappi M; Borini A
Curr Pharm Des; 2012; 18(3):293-302. PubMed ID: 22229566
[TBL] [Abstract][Full Text] [Related]
51. [Possibilities of cryopreservation of ovarian tissue for fertility preservation in cancer patients].
Gamzatoval ZKh; Komlichenko EV; Kostareva AA; Galagudza MM; Berlev IV; Urmancheeva AF; Ulrikh EA; Malashicheva AB; Belyakova MV; Molotkova MY
Vopr Onkol; 2015; 61(2):199-204. PubMed ID: 26087598
[TBL] [Abstract][Full Text] [Related]
52. Construction and cryopreservation of an artificial ovary in cancer patients as an element of cancer therapy and a promising approach to fertility restoration.
Chen J; Todorov P; Isachenko E; Rahimi G; Mallmann P; Isachenko V
Hum Fertil (Camb); 2022 Oct; 25(4):651-661. PubMed ID: 33648431
[TBL] [Abstract][Full Text] [Related]
53. The development of ovarian tissue cryopreservation in Edinburgh: Translation from a rodent model through validation in a large mammal and then into clinical practice.
Anderson RA; Baird DT
Acta Obstet Gynecol Scand; 2019 May; 98(5):545-549. PubMed ID: 30723908
[TBL] [Abstract][Full Text] [Related]
54. Developmental competence of oocytes isolated from surplus medulla tissue in connection with cryopreservation of ovarian tissue for fertility preservation.
Wilken-Jensen HN; Kristensen SG; Jeppesen JV; Yding Andersen C
Acta Obstet Gynecol Scand; 2014 Jan; 93(1):32-7. PubMed ID: 24111534
[TBL] [Abstract][Full Text] [Related]
55. Genomic Consideration in Chemotherapy-Induced Ovarian Damage and Fertility Preservation.
Kim S; Lee S; Park HT; Song JY; Kim T
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680919
[TBL] [Abstract][Full Text] [Related]
56. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
[TBL] [Abstract][Full Text] [Related]
57. Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage.
Kim S; Kim SW; Han SJ; Lee S; Park HT; Song JY; Kim T
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299104
[TBL] [Abstract][Full Text] [Related]
58. [Fertility preservation in oncology].
Chaput L; Grémeau AS; Vorilhon S; Pons H; Chabrot C; Grèze V; Pouly JL; Brugnon F
Bull Cancer; 2018 Jan; 105(1):99-110. PubMed ID: 29221621
[TBL] [Abstract][Full Text] [Related]
59. [Fertility preservation in breast cancer patients: the state of art in 2014?].
Comtet M; Sonigo C; Valdelièvre C; Sermondade N; Sifer C; Grynberg M
Bull Cancer; 2015 May; 102(5):443-53. PubMed ID: 25739327
[TBL] [Abstract][Full Text] [Related]
60. Expectations and limitations of ovarian tissue transplantation.
Donfack NJ; Alves KA; Araújo VR; Cordova A; Figueiredo JR; Smitz J; Rodrigues APR
Zygote; 2017 Aug; 25(4):391-403. PubMed ID: 28766468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
